精华制药：玛巴洛沙韦产品工艺优化工作尚在推进中

Core Viewpoint - Jinghua Pharmaceutical (002349) is currently in the process of optimizing the production process for its product Mabalosavir, and it has not yet reached the conditions necessary for commercial production and sales [1] Company Summary - The company is actively working on the process optimization of Mabalosavir [1] - As of now, the product is not ready for commercial production and sales [1]